Symbols / HQL Stock $17.27 -0.80% Abrdn Life Sciences Investors
HQL (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Ratings
Current target
$17.27
Low
—
High
—
Mean
—
News
RSS: Latest HQL news- abrdn Life (HQL) Stock Low Risk Entry (Slow Drop) 2026-04-20 - Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 20 Apr 2026 15
- Price-Driven Insight from (HQL) for Rule-Based Strategy - Stock Traders Daily ue, 21 Apr 2026 14
- abrdn Life Sciences Investors (NYSE:HQL) Sets New 1-Year High - Here's Why - MarketBeat Mon, 20 Apr 2026 15
- abrdn Life (HQL) Stock: Reversal Setup? (Trend Strengthens) 2026-04-18 - Trending Picks - Cổng thông tin điện tử Tỉnh Sơn La Sat, 18 Apr 2026 12
- Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan Mon, 23 Feb 2026 08
- abrdn Life (HQL) Stock: Reversal Setup? (Trend Strengthens) 2026-04-18 - Fibonacci Analysis - Cổng thông tin điện tử tỉnh Lào Cai Sat, 18 Apr 2026 12
- HQL CEF: Still Offers Attractive Value As Long As Interest Rates Decline (NYSE:HQL) - Seeking Alpha hu, 06 Nov 2025 08
- HQL Forecast — Price Prediction for 2026. Should I Buy HQL? - Intellectia AI Sat, 17 Jan 2026 16
- Shaker Financial Services LLC Has $1.94 Million Holdings in abrdn Life Sciences Investors $HQL - MarketBeat Sat, 18 Apr 2026 11
- (HQL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily Fri, 10 Apr 2026 13
- Will abrdn Life (HQL) Stock Outperform Peers | Price at $17.00, Up 0.95% - Global Trading Community - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 06 Apr 2026 07
- HQL SEC Filings - abrdn Life Sciences Investors 10-K, 10-Q, 8-K Forms - Stock Titan ue, 22 Jul 2025 19
- abrdn Life Sciences Investors (NYSE:HQL) Short Interest Up 22.2% in March - MarketBeat hu, 16 Apr 2026 20
- Is abrdn Life (HQL) Stock a Safe Investment | Price at $17.22, Up 0.34% - Pro Level Trade Signals - Xã Thanh Hà Sat, 28 Mar 2026 07
- abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week High - Still a Buy? - MarketBeat ue, 14 Apr 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
86.39
-0.35%
|
86.69
+268.50%
|
23.52
+122.78%
|
-103.25
|
| Operating Revenue |
|
86.39
-0.35%
|
86.69
+268.50%
|
23.52
+122.78%
|
-103.25
|
| Operating Expense |
|
0.79
-43.00%
|
1.39
+18.55%
|
1.17
-13.40%
|
1.35
|
| Selling General And Administration |
|
0.74
-44.21%
|
1.33
+47.50%
|
0.90
-16.12%
|
1.08
|
| General And Administrative Expense |
|
0.74
-44.21%
|
1.33
+47.50%
|
0.90
-16.12%
|
1.08
|
| Other Operating Expenses |
|
0.05
-14.57%
|
0.06
-78.88%
|
0.27
-2.77%
|
0.28
|
| Net Income |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Pretax Income |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Net Interest Income |
|
0.35
-66.46%
|
1.04
+410.22%
|
0.20
+308.15%
|
0.05
|
| Interest Income |
|
0.35
-66.46%
|
1.04
+410.22%
|
0.20
+308.15%
|
0.05
|
| Gain On Sale Of Security |
|
27.89
-12.71%
|
31.96
-10.95%
|
35.89
+24.42%
|
28.84
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Net Income From Continuing And Discontinued Operation |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Net Income Continuous Operations |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Normalized Income |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Net Income Common Stockholders |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Diluted EPS |
|
—
|
3.04
+284.81%
|
0.79
+118.54%
|
-4.26
|
| Basic EPS |
|
—
|
3.04
+284.81%
|
0.79
+118.54%
|
-4.26
|
| Basic Average Shares |
|
—
|
28.06
-0.83%
|
28.29
+15.23%
|
24.55
|
| Diluted Average Shares |
|
—
|
28.06
-0.83%
|
28.29
+15.23%
|
24.55
|
| Diluted NI Availto Com Stockholders |
|
85.59
+0.35%
|
85.30
+281.60%
|
22.35
+121.37%
|
-104.60
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Assets |
|
515.38
+11.90%
|
460.58
+14.40%
|
402.60
-2.92%
|
414.73
|
| Cash And Cash Equivalents |
|
0.08
+7553700.00%
|
0.00
-99.79%
|
0.00
+7.19%
|
0.00
|
| Cash Financial |
|
0.08
+7553700.00%
|
0.00
-99.79%
|
0.00
+7.19%
|
0.00
|
| Receivables |
|
1.14
+392.46%
|
0.23
-95.42%
|
5.04
+709.12%
|
0.62
|
| Taxes Receivable |
|
0.01
+0.00%
|
0.01
|
—
|
—
|
| Prepaid Assets |
|
0.04
-6.43%
|
0.04
+59.18%
|
0.03
+3.63%
|
0.03
|
| Investments And Advances |
|
514.12
+11.69%
|
460.30
+15.79%
|
397.53
-4.00%
|
414.08
|
| Total Liabilities Net Minority Interest |
|
1.73
+94.24%
|
0.89
+33.23%
|
0.67
-96.04%
|
16.82
|
| Payables |
|
1.17
+148.67%
|
0.47
|
—
|
16.19
|
| Accounts Payable |
|
0.72
+40151.31%
|
0.00
|
—
|
5.10
|
| Other Payable |
|
0.45
-4.28%
|
0.47
|
—
|
11.09
|
| Stockholders Equity |
|
513.66
+11.74%
|
459.69
+14.37%
|
401.93
+1.01%
|
397.90
|
| Common Stock Equity |
|
513.66
+11.74%
|
459.69
+14.37%
|
401.93
+1.01%
|
397.90
|
| Capital Stock |
|
0.30
+5.48%
|
0.28
+4.74%
|
0.27
+4.33%
|
0.26
|
| Common Stock |
|
0.30
+5.48%
|
0.28
+4.74%
|
0.27
+4.33%
|
0.26
|
| Share Issued |
|
29.60
+5.48%
|
28.06
+4.74%
|
26.79
+4.33%
|
25.68
|
| Ordinary Shares Number |
|
29.60
+5.48%
|
28.06
+4.74%
|
26.79
+4.33%
|
25.68
|
| Additional Paid In Capital |
|
435.76
+4.93%
|
415.29
+3.01%
|
403.15
+3.88%
|
388.10
|
| Retained Earnings |
|
77.60
+75.86%
|
44.13
+3079.17%
|
-1.48
-115.51%
|
9.55
|
| Total Equity Gross Minority Interest |
|
513.66
+11.74%
|
459.69
+14.37%
|
401.93
+1.01%
|
397.90
|
| Net Tangible Assets |
|
513.66
+11.74%
|
459.69
+14.37%
|
401.93
+1.01%
|
397.90
|
| Tangible Book Value |
|
513.66
+11.74%
|
459.69
+14.37%
|
401.93
+1.01%
|
397.90
|
| Available For Sale Securities |
|
8.42
-51.15%
|
17.23
|
—
|
—
|
| Cash Cash Equivalents And Federal Funds Sold |
|
0.08
+7553700.00%
|
0.00
-99.79%
|
0.00
+7.19%
|
0.00
|
| Derivative Product Liabilities |
|
0.43
+755.06%
|
0.05
|
—
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
505.70
+14.14%
|
443.07
+11.46%
|
397.53
-4.00%
|
414.08
|
| Investmentin Financial Assets |
|
514.12
+11.69%
|
460.30
+15.79%
|
397.53
-4.00%
|
414.08
|
| Line Item | Trend | 2025-09-30 |
|---|---|---|
| Operating Cash Flow |
|
31.71
|
| Net Income From Continuing Operations |
|
85.59
|
| Other Non Cash Items |
|
0.06
|
| Gain Loss On Investment Securities |
|
-53.68
|
| Change In Working Capital |
|
-0.26
|
| Change In Prepaid Assets |
|
0.00
|
| Change In Accrued Expense |
|
-0.27
|
| Change In Payable |
|
0.00
|
| Change In Other Current Liabilities |
|
0.00
|
| Financing Cash Flow |
|
-31.63
|
| Common Stock Dividend Paid |
|
-31.63
|
| Cash Dividends Paid |
|
-31.63
|
| Net Other Financing Charges |
|
0.00
|
| Changes In Cash |
|
0.08
|
| Beginning Cash Position |
|
0.00
|
| End Cash Position |
|
0.08
|
| Free Cash Flow |
|
31.71
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42025-12-18 View
- 42025-09-23 View
- 42025-09-19 View
- 42025-09-17 View
- 42025-09-15 View
- 42025-09-04 View
- 42025-09-02 View
- 42025-08-27 View
- 42025-08-25 View
- 42025-05-22 View
- 42025-05-19 View
- 42025-05-15 View
- 42025-05-12 View
- 42025-05-08 View
- 42025-04-21 View
- 42025-04-17 View
- 42025-04-15 View
- 42025-04-14 View
- 42025-04-07 View
- 42025-04-03 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|